Study International Multicentric Pancreatic Left Resections (SIMPLR): Does Surgical Approach Matter?
- PMID: 38473411
- PMCID: PMC10931444
- DOI: 10.3390/cancers16051051
Study International Multicentric Pancreatic Left Resections (SIMPLR): Does Surgical Approach Matter?
Abstract
Background: Minimally invasive surgery is increasingly preferred for left-sided pancreatic resections. The SIMPLR study aims to compare open, laparoscopic, and robotic approaches using propensity score matching analysis.
Methods: This study included 258 patients with tumors of the left side of the pancreas who underwent surgery between 2016 and 2020 at three high-volume centers. The patients were divided into three groups based on their surgical approach and matched in a 1:1 ratio.
Results: The open group had significantly higher estimated blood loss (620 mL vs. 320 mL, p < 0.001), longer operative time (273 vs. 216 min, p = 0.003), and longer hospital stays (16.9 vs. 6.81 days, p < 0.001) compared to the laparoscopic group. There was no difference in lymph node yield or resection status. When comparing open and robotic groups, the robotic procedures yielded a higher number of lymph nodes (24.9 vs. 15.2, p = 0.011) without being significantly longer. The laparoscopic group had a shorter operative time (210 vs. 340 min, p < 0.001), shorter ICU stays (0.63 vs. 1.64 days, p < 0.001), and shorter hospital stays (6.61 vs. 11.8 days, p < 0.001) when compared to the robotic group. There was no difference in morbidity or mortality between the three techniques.
Conclusion: The laparoscopic approach exhibits short-term benefits. The three techniques are equivalent in terms of oncological safety, morbidity, and mortality.
Keywords: international; laparoscopy; left pancreatic resection; minimally invasive; multicentric; robotic surgery.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy.Surg Endosc. 2021 Apr;35(4):1675-1681. doi: 10.1007/s00464-020-07551-2. Epub 2020 Apr 10. Surg Endosc. 2021. PMID: 32277354
-
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.Lancet Gastroenterol Hepatol. 2022 Nov;7(11):991-1004. doi: 10.1016/S2468-1253(22)00248-5. Epub 2022 Sep 8. Lancet Gastroenterol Hepatol. 2022. PMID: 36087608 Clinical Trial.
-
Impact of shifting from laparoscopic to robotic surgery during 600 minimally invasive pancreatic and liver resections.Surg Endosc. 2023 Apr;37(4):2659-2672. doi: 10.1007/s00464-022-09735-4. Epub 2022 Nov 18. Surg Endosc. 2023. PMID: 36401105 Free PMC article.
-
Oncological outcomes of open, laparoscopic and robotic colectomy in patients with transverse colon cancer.Tech Coloproctol. 2022 Oct;26(10):821-830. doi: 10.1007/s10151-022-02650-9. Epub 2022 Jul 8. Tech Coloproctol. 2022. PMID: 35804251
-
Should all distal pancreatectomies be performed laparoscopically?Adv Surg. 2009;43:283-300. doi: 10.1016/j.yasu.2009.02.013. Adv Surg. 2009. PMID: 19845186 Review.
References
-
- Cuschieri A. Laparoscopic surgery of the pancreas. J. R. Coll. Surg. Edinb. 1994;39:178–184. - PubMed
-
- Asbun H.J., Moekotte A.L., Vissers F.L., Kunzler F., Cipriani F., Alseidi A., D’Angelica M.I., Balduzzi A., Bassi C., Bjornsson B., et al. The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection. Ann. Surg. 2020;271:1–14. doi: 10.1097/SLA.0000000000003590. - DOI - PubMed
-
- van Ramshorst T.M.E., van Hilst J., Bannone E., Pulvirenti A., Asbun H.J., Boggi U., Busch O.R., Dokmak S., Edwin B., Hogg M., et al. International survey on opinions and use of robot-assisted and laparoscopic minimally invasive pancreatic surgery: 5-year follow up. HPB. 2023;26:63–72. doi: 10.1016/j.hpb.2023.09.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources